Clinilabs is thrilled to announce our participation in the upcoming 18th annual CTAD conference (CTAD25), happening from December 1-4, 2025, in beautiful San Diego, California. This is not just another conference—it’s a pivotal opportunity for professionals in Alzheimer’s disease diagnostics and therapeutics to connect, share insights, and collaborate on groundbreaking research.

Join us as we engage with leading experts and discuss the latest advancements in clinical research aimed at transforming the treatment landscape for Alzheimer’s disease. At Clinilabs, we believe in the power of collaboration to drive innovation and deliver real change in patient care. Together, we can advance new treatment options that have the potential to make a significant impact. Don’t miss your chance to meet with us to discuss your upcoming clinical trial needs. Book now before it is too late.

About CTAD: The Clinical Trials on Alzheimer’s Disease (CTAD) Conference has been a cornerstone event in the field since its inception in 2008. Designed by and for Alzheimer’s researchers, its mission is to encourage meaningful, research-focused dialogue and collaboration. With its intimate and collegial atmosphere, CTAD has established itself as a forum for impactful international partnerships, making strides in the global Alzheimer’s research agenda.